Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather L Gardner

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Veterinary Internal Medicine|April 25, 2024
Safety and biologic activity of a canine anti-CD20 monoclonal antibody in dogs with diffuse large B-cell lymphomaGretchen P McLinden, Anne C Avery, Heather L Gardner, et al.
Plos One|September 13, 2022
The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterationsKate Megquier, Jason Turner-Maier, Kathleen Morrill, et al.
Plos One|June 10, 2025
Characterization of the genomic landscape of canine oral osteosarcoma reveals similarities with appendicular osteosarcomaChristopher Husted, Sarah Adrianowycz, Cornelia Peterson, et al.
Plos One|August 25, 2023
Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphomaKatherine Dittrich, Ümmügülsüm Yıldız-Altay, Fatima Qutab, et al.
Scientific Reports|March 18, 2026
Peripheral blood mononuclear cell gene expression signatures predict long-term survivorship in canine DLBCLKirthana Rao, Zechuan Rao, Angelina Huang, et al.
Research Square|September 2, 2025
Peripheral Blood Mononuclear Cell Gene Expression Signatures Predict Long-term Survivorship in Canine DLBCLKirthana Rao, Zechuan Rao, Angelina Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2018
Consecutive Day HSP90 Inhibitor Administration Improves Efficacy in Murine Models of KIT-Driven Malignancies and Canine Mast Cell TumorsCheryl A London, Jaime Acquaviva, Donald L Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2016
KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast CellsCheryl A London, Heather L Gardner, Sarah Rippy, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Multi-omic Longitudinal Analysis of Canine Osteosarcoma Identifies Inter-Patient Heterogeneity and Immune Enrichment in Metastatic LesionsChristopher Husted, Kerstin Seidel, Tanya T Karagiannis, et al.
BMC Veterinary Research|August 26, 2018
Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphomaAbbey R Sadowski, Heather L Gardner, Antonella Borgatti, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Veterinary Internal Medicine|April 25, 2024
Safety and biologic activity of a canine anti-CD20 monoclonal antibody in dogs with diffuse large B-cell lymphomaGretchen P McLinden, Anne C Avery, Heather L Gardner, et al.
Plos One|September 13, 2022
The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterationsKate Megquier, Jason Turner-Maier, Kathleen Morrill, et al.
Plos One|June 10, 2025
Characterization of the genomic landscape of canine oral osteosarcoma reveals similarities with appendicular osteosarcomaChristopher Husted, Sarah Adrianowycz, Cornelia Peterson, et al.
Plos One|August 25, 2023
Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphomaKatherine Dittrich, Ümmügülsüm Yıldız-Altay, Fatima Qutab, et al.
Scientific Reports|March 18, 2026
Peripheral blood mononuclear cell gene expression signatures predict long-term survivorship in canine DLBCLKirthana Rao, Zechuan Rao, Angelina Huang, et al.
Research Square|September 2, 2025
Peripheral Blood Mononuclear Cell Gene Expression Signatures Predict Long-term Survivorship in Canine DLBCLKirthana Rao, Zechuan Rao, Angelina Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2018
Consecutive Day HSP90 Inhibitor Administration Improves Efficacy in Murine Models of KIT-Driven Malignancies and Canine Mast Cell TumorsCheryl A London, Jaime Acquaviva, Donald L Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2016
KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast CellsCheryl A London, Heather L Gardner, Sarah Rippy, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Multi-omic Longitudinal Analysis of Canine Osteosarcoma Identifies Inter-Patient Heterogeneity and Immune Enrichment in Metastatic LesionsChristopher Husted, Kerstin Seidel, Tanya T Karagiannis, et al.
BMC Veterinary Research|August 26, 2018
Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphomaAbbey R Sadowski, Heather L Gardner, Antonella Borgatti, et al.
Pageof 4